A Platform Technology
TEI’s scientists are recognized for uncovering the key principles of tissue engineering. Our products are based on pioneering research and development that originated in the labs of the Massachusetts Institute of Technology (MIT). TEI’s core understanding of the principles of tissue engineering spans over three decades. Our expertise led to the development of a platform technology that enables soft tissue repair for clinical applications that include:
We’re just getting started….
TEI’s collagen matrix technology is able to carry agents that can play specific roles in the reconstructive process. A first example of such an FDA cleared application is in wound care. Our PriMatrix Ag product line makes use of silver ion technology, which protects the device against bacterial colonization. We continue to explore the science of binding different types of growth factors and cells to our matrix technology, which holds the future promise of faster healing and better outcomes. By doing so, TEI plans to deliver solutions for the unmet clinical needs in disease states such as cancer, diabetes and arthritis.